Supernus Pharm
(SUPN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SUPN | TEVA | BBIO | RDY | BHC |
| Company | Supernus Pharm | Teva Pharmaceutical Industries ADR | Bridgebio Pharma Inc | Dr. Reddy's Laboratories Ltd ADR | Bausch Health Companies Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NYSE |
| Open | 50.01 | 35.00 | 70.07 | 14.14 | 5.78 |
| High | 51.99 | 35.11 | 70.63 | 14.14 | 5.90 |
| Low | 50.01 | 34.61 | 67.59 | 13.84 | 5.77 |
| Latest | 51.65 | 34.69 | 68.05 | 14.08 | 5.88 |
| Change | +2.28 | -0.11 | +4.32 | +0.11 | +0.15 |
| % Change | +4.62% | -0.32% | +6.78% | +0.79% | +2.62% |
| Volume | 893,900 | 7,035,900 | 4,742,000 | 2,901,000 | 1,364,000 |
| 20-Day Average Volume | 755,135 | 11,530,135 | 3,304,820 | 2,130,270 | 2,182,870 |
| Previous Close | 49.37 | 34.80 | 63.73 | 13.97 | 5.73 |
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 49.74 | 33.08 | 76.48 | 13.50 | 6.36 |
| 20-Day Raw Stochastic | 83.69% | 60.05% | 28.19% | 95.49% | 14.29% |
| 20-Day Relative Strength | 59.71 | 66.89 | 40.86 | 56.91 | 38.83 |
| Weighted Alpha | +43.96 | +137.43 | +105.36 | +1.21 | -28.48 |
| Today's Opinion | 96% Buy | 100% Buy | 56% Buy | 40% Sell | 24% Sell |
| Previous Opinion | 72% Buy | 100% Buy | 48% Buy | 48% Sell | 24% Sell |
| Last Month's Opinion | 100% Buy | 100% Buy | 80% Buy | 80% Sell | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.25% since 01/30/26 | +1.79% since 01/30/26 | -11.93% since 01/30/26 | +4.92% since 01/30/26 | +2.44% since 01/30/26 |
| Low | 47.29 on 02/03/26 | 34.15 on 02/02/26 | 62.84 on 02/05/26 | 12.95 on 02/02/26 | 5.59 on 02/03/26 |
| High | 51.99 on 02/06/26 | 37.35 on 02/03/26 | 80.00 on 02/03/26 | 14.14 on 02/06/26 | 5.89 on 02/06/26 |
| 1-Month | |||||
| %Chg | +4.85% since 01/06/26 | +8.03% since 01/06/26 | -8.03% since 01/06/26 | +1.59% since 01/06/26 | -22.94% since 01/06/26 |
| Low | 47.29 on 02/03/26 | 30.70 on 01/20/26 | 62.84 on 02/05/26 | 12.81 on 01/20/26 | 5.55 on 01/30/26 |
| High | 52.50 on 01/12/26 | 37.35 on 02/03/26 | 81.32 on 01/22/26 | 14.14 on 02/06/26 | 8.00 on 01/07/26 |
| 3-Month | |||||
| %Chg | +9.28% since 11/06/25 | +41.82% since 11/06/25 | +8.48% since 11/06/25 | +4.53% since 11/06/25 | -12.11% since 11/06/25 |
| Low | 44.05 on 11/18/25 | 23.61 on 11/07/25 | 60.55 on 11/07/25 | 12.81 on 01/20/26 | 5.55 on 01/30/26 |
| High | 52.50 on 01/12/26 | 37.35 on 02/03/26 | 81.32 on 01/22/26 | 14.32 on 12/23/25 | 8.00 on 01/07/26 |
| 6-Month | |||||
| %Chg | +21.70% since 08/06/25 | +116.68% since 08/06/25 | +51.86% since 08/06/25 | +5.63% since 08/06/25 | +2.08% since 08/06/25 |
| Low | 40.26 on 08/08/25 | 16.05 on 08/07/25 | 44.10 on 08/07/25 | 12.81 on 01/20/26 | 5.55 on 01/30/26 |
| High | 57.65 on 10/30/25 | 37.35 on 02/03/26 | 81.32 on 01/22/26 | 15.06 on 09/17/25 | 8.69 on 08/15/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,830,826 | 39,914,204 | 12,281,344 | 11,664,084 | 2,125,074 |
| Shares Outstanding, K | 57,339 | 1,146,960 | 192,709 | 834,938 | 370,868 |
| Annual Sales | 661,820,000 | 17,258,000,000 | 221,900,000 | 3,811,000,000 | 9,625,000,000 |
| Annual Net Income | 73,870,000 | 1,410,000,000 | -535,760,000 | 663,000,000 | -46,000,000 |
| Last Quarter Sales | 192,100,000 | 4,711,000,000 | 120,700,000 | 977,400,000 | 2,681,000,000 |
| Last Quarter Net Income | -45,120,000 | 480,000,000 | -182,740,000 | 135,500,000 | 179,000,000 |
| 60-Month Beta | 0.71 | 0.70 | 1.13 | 0.35 | 0.42 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.01 on 11/04/25 | 0.96 on 01/28/26 | -0.95 on 10/29/25 | 0.19 on 10/24/25 | 1.16 on 10/29/25 |
| Latest Earnings Date | 02/24/26 | 05/06/26 | 02/19/26 | 05/08/26 | 02/18/26 |
| Most Recent Dividend | N/A | 0.072 on 11/27/17 | N/A | 0.071 on 07/25/25 | 1.000 on 11/10/10 |
| Next Ex-Dividends Date | N/A | 11/27/17 | N/A | 07/25/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 23.04 | 12.44 | 0.00 | 18.18 | 1.49 |